Skip to content

A clinical study on cegana vadham with Maavilinga pattai ottradam[External therapy] Kethagi Thailam[Extenal Medicine] and Perarathai Chooranam[Internal Medicine]

An open labelled double arm non randomized phase II clinical trial,to evaluate the therapeutic efficacy of Maavilinga pattai ottradam[External medicine] Kethagi Thailam[External medicine] Perarathai chooranam[Internal medicine] in the management of Cegana Vadham[Cervical Spondylosis]

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/026958
Enrollment
40
Registered
2020-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M472- Other spondylosis with radiculopathy

Interventions

Intervention1: Ottradam external Therapy: Ottradam external Therapy 48 Days Control Intervention1: Nil: Nil

Sponsors

Government siddha medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neck pain Radiating pain towards upper limbs with or without numbness in the upper limbs giddiness and neck stiffness Patients who are willing to give blood samples for laboratory investigation Patients who are willling to take x ray before and after treatment willing for admission in IPD for 48 days or willing to OPD regularly Patients who are willing to participate in this study with knowledge of potential risks and who are willing to sign the informed consent

Exclusion criteria

Exclusion criteria: Cardiac Disease Benign and malignant Neoplasm spina bifida ankylosing spondylosis Congenital anomalies of spine Severe Osteoporosis of cervical spine Cervical rib pregnant women and lactating mother Trauma Syringomyelia Tuberculosis in spine Diabetes mellitus

Design outcomes

Primary

MeasureTime frame
Assessment of changes from baseline in universal pain assessment scale score at day 48 between Group I (Ottradam External therapy) and Group II (Medicine and Ottradam external therapy) Comparison of efficacy in patient Group I and Group IITimepoint: 48 Days

Secondary

MeasureTime frame
Assessment of quality of life by universal pain score scale Assessment of safety parametersTimepoint: 48 Days

Countries

India

Contacts

Public ContactDr M Ahamed Mohideen

Government Siddha Medical College and Hospital

dr.ahmed63@gmail.com9442542282

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026